Radiation exposure to the lens of the eye for Japanese nuclear power plant workers.

Hp (10) Hp (3) equivalent dose of the lens of the eye nuclear power plant workers ratio of eye lens dose to effective dose

Journal

Journal of radiological protection : official journal of the Society for Radiological Protection
ISSN: 1361-6498
Titre abrégé: J Radiol Prot
Pays: England
ID NLM: 8809257

Informations de publication

Date de publication:
19 07 2022
Historique:
received: 27 08 2021
accepted: 15 06 2022
pubmed: 16 6 2022
medline: 22 7 2022
entrez: 15 6 2022
Statut: epublish

Résumé

In Japan, the radiation-dose limit for the lens of the eye was revised in April 2021. Consequently, for workers, the numerical values of the equivalent dose to the lens of the eye are equal to those of the effective dose. Radiation workers, radiation safety officers and licensees must comply with regulations related to radiation protection and optimize protection. The new guidelines on dose monitoring of the lens of the eye developed by the Japan Health Physics Society recommend for the dose to be estimated near the eye for accurate estimation, when the dose to the lens approaches or exceeds the management criteria. However, there is limited information regarding the non-uniform exposure of nuclear power plant workers. In this study, the dose equivalents of high-dose-rate workplaces and the personal doses of 88 workers were estimated at four Japanese commercial nuclear power plant sites (RWR: 3 units and BWR: 3 units) and the dose to the lens of the eye and the exposure situations of the workers were analyzed.

Identifiants

pubmed: 35705021
doi: 10.1088/1361-6498/ac7913
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2022 Society for Radiological Protection. Published on behalf of SRP by IOP Publishing Limited. All rights reserved.

Auteurs

Sumi Yokoyama (S)

Research Promotion Headquarters, Fujita Health University, 1-98 Dengakugakubo Kutsukakecho, Toyoake, Aichi 470-1192, Japan.

Hideo Tatsuzaki (H)

Department of Radiation Emergency Medicine, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology (QST), 4-9-1 Anakawa Inage, Chiba 263-8555, Japan.

Yoshihiko Tanimura (Y)

Department of Radiation Protection, Nuclear Science Research Institute, Japan Atomic Energy Agency, Muramatsu, Tokai-mura, Ibaraki 319-1195, Japan.

Hiroshi Yoshitomi (H)

Department of Radiation Protection, Nuclear Science Research Institute, Japan Atomic Energy Agency, Muramatsu, Tokai-mura, Ibaraki 319-1195, Japan.

Shigekazu Hirao (S)

Institute of Environmental Radioactivity, Fukushima University, 1 Kanayagawa, Fukushima-shi, Fukushima 960-1296, Japan.

Katsunori Aoki (K)

Safety and Facility Management Section, Tono Geoscience Center, Japan Atomic Energy Agency, 959-31, Jorinji, Izumicho, Toki, Gifu 509-5102, Japan.

Shuichi Tachiki (S)

School of Medical Sciences, Fujita Health University, 1-98 Dengakugakubo Kutsukakecho, Toyoake, Aichi 470-1192, Japan.

Iwao Ezaki (I)

Chiyoda Technol Corporation, 1-7-2 Yushima, Bunkyo, Tokyo 113-8681, Japan.

Katsuya Hoshi (K)

Radiation Protection Department, Nuclear Fuel Cycle Engineering Laboratories, Japan Atomic Energy Agency, 4-33, Muramatsu, Tokai-mura, Ibaraki 319-1194, Japan.

Norio Tsujimura (N)

Radiation Protection Department, Nuclear Fuel Cycle Engineering Laboratories, Japan Atomic Energy Agency, 4-33, Muramatsu, Tokai-mura, Ibaraki 319-1194, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH